Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Zenith® Fenestrated+ klinisk undersøgelse

1. oktober 2026 opdateret af: Cook Research Incorporated

Zenith® Fenestrated+ Endovaskulær graft klinisk undersøgelse

The Zenith® Fenestrated+ Endovascular Graft Clinical Study will assess the safety and effectiveness of the Zenith® Fenestrated+ Endovascular Graft (ZFEN+) in combination with the BeGraft Balloon-Expandable FEVAR Bridging Stent Graft System (BeGraft) and Unibody2 for the treatment of patients with aortic aneurysms involving one or more of the major visceral arteries.

Up to 130 additional subjects may be enrolled in Continued Access phase of the study

Studieoversigt

Status

Rekruttering

Betingelser

Intervention / Behandling

Undersøgelsestype

Interventionel

Tilmelding (Anslået)

105

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiekontakt

Undersøgelse Kontakt Backup

Studiesteder

      • London, Det Forenede Kongerige, SE1 7EH
        • Aktiv, ikke rekrutterende
        • St Thomas' Hospital
    • Alabama
      • Birmingham, Alabama, Forenede Stater, 35294
        • Rekruttering
        • University of Alabama Birmingham Hospital
        • Kontakt:
          • Adam Beck, MD
    • California
      • La Jolla, California, Forenede Stater, 92037
        • Rekruttering
        • UC San Diego
        • Kontakt:
          • Mahmoud Malas, MD
      • Los Angeles, California, Forenede Stater, 90031
        • Rekruttering
        • University of Southern California
        • Kontakt:
          • Sukgu Han, MD
      • Stanford, California, Forenede Stater, 94305
        • Rekruttering
        • Stanford Hospitals and Clinics
        • Kontakt:
          • Jason Lee, MD
    • District of Columbia
      • Washington D.C., District of Columbia, Forenede Stater, 20010
        • Rekruttering
        • Medstar Washington Hospital Center
        • Kontakt:
          • Steven Abramowitz, MD
    • Florida
      • Gainesville, Florida, Forenede Stater, 32610
        • Rekruttering
        • University of Florida Shands Hospital
        • Kontakt:
          • Zain Shahid, MD
      • Tampa, Florida, Forenede Stater, 33606
        • Rekruttering
        • Tampa General Hospital
        • Kontakt:
          • Dean Arnaoutakis, MD
    • Georgia
      • Atlanta, Georgia, Forenede Stater, 30322
        • Rekruttering
        • Emory University Hospital
        • Kontakt:
          • Yazan Duwayri, MD
    • Illinois
      • Chicago, Illinois, Forenede Stater, 60611
        • Rekruttering
        • Northwestern Memorial Hospital
        • Kontakt:
          • Neel Mansukhani, MD
      • Glenview, Illinois, Forenede Stater, 60026
        • Rekruttering
        • Endeavor Health Cardiovascular Institute at Glenbrook Hospital
        • Kontakt:
          • George Pontikis
      • Maywood, Illinois, Forenede Stater, 60153
        • Rekruttering
        • Loyola University Medical Center
        • Kontakt:
          • Michael Soult, MD
      • Naperville, Illinois, Forenede Stater, 60540
        • Rekruttering
        • Edward Hospital
        • Kontakt:
          • George Pontikis, MD
        • Ledende efterforsker:
          • George Pontikis, MD
    • Indiana
      • Indianapolis, Indiana, Forenede Stater, 46202
        • Rekruttering
        • Methodist Hospital of Indiana
        • Kontakt:
          • Andres Fajardo, MD
    • Maryland
      • Baltimore, Maryland, Forenede Stater, 21201
        • Rekruttering
        • University of Maryland
        • Kontakt:
          • Shahab Toursavadkohi, MD
    • Massachusetts
      • Boston, Massachusetts, Forenede Stater, 02215
        • Rekruttering
        • Beth Israel Deaconess Medical Center
        • Kontakt:
          • Marc Schermerhorn, MD
      • Boston, Massachusetts, Forenede Stater, 02114
        • Afsluttet
        • Massachusetts General Hospital
      • Worcester, Massachusetts, Forenede Stater, 01655
        • Rekruttering
        • University of Massachusetts
        • Kontakt:
          • Andres Schanzer, MD
    • Michigan
      • Ann Arbor, Michigan, Forenede Stater, 48109
        • Rekruttering
        • University of Michigan Health System
        • Kontakt:
          • Jonathan Eliason, MD
    • Minnesota
      • Rochester, Minnesota, Forenede Stater, 55905
        • Rekruttering
        • Mayo Clinic
        • Kontakt:
          • Randall DeMartino, MD
    • Missouri
      • St Louis, Missouri, Forenede Stater, 63110
        • Rekruttering
        • Barnes Jewish Hospital
        • Kontakt:
          • John Ohman, MD
    • New Hampshire
      • Lebanon, New Hampshire, Forenede Stater, 03756
        • Rekruttering
        • Dartmouth-Hitchcock Medical Center
        • Kontakt:
          • Bjoern Suckow, MD
    • New York
      • New York, New York, Forenede Stater, 10016
        • Rekruttering
        • New York University Langone Medical Center
        • Kontakt:
          • Thomas Maldonado, MD
      • New York, New York, Forenede Stater, 10032
        • Rekruttering
        • Columbia University Irving Medical Center/NY Presbyterian Hospital
        • Kontakt:
          • Virenda Patel
    • North Carolina
      • Chapel Hill, North Carolina, Forenede Stater, 27599
        • Rekruttering
        • University of North Carolina at Chapel Hill
        • Kontakt:
          • Federico Parodi, MD
    • Ohio
      • Cleveland, Ohio, Forenede Stater, 44195
        • Rekruttering
        • Cleveland Clinic Foundation
        • Kontakt:
          • Francis Caputo, MD
    • Pennsylvania
      • Philadelphia, Pennsylvania, Forenede Stater, 19104
        • Rekruttering
        • Hospital of the University of Pennsylvania
        • Kontakt:
          • Grace Wang, MD
      • Pittsburgh, Pennsylvania, Forenede Stater, 15213
        • Rekruttering
        • University of Pittsburgh Medical Center
        • Kontakt:
          • Nathan Liang
    • South Carolina
      • Charleston, South Carolina, Forenede Stater, 29425
        • Rekruttering
        • Medical University of South Carolina
        • Kontakt:
          • Ravi Veeraswamy, MD
    • Tennessee
      • Kingsport, Tennessee, Forenede Stater, 37660
        • Rekruttering
        • Holston Valley Hospital
        • Kontakt:
          • Robert "Bo" Allen, MD
    • Texas
      • Dallas, Texas, Forenede Stater, 75235
        • Rekruttering
        • Ut Southwestern
        • Kontakt:
          • Mirza Baig, MD
      • Houston, Texas, Forenede Stater, 77030
        • Rekruttering
        • Memorial Hermann Texas Medical Center/UT Health
        • Kontakt:
          • Naveed Saqib, MD
    • Virginia
      • Roanoke, Virginia, Forenede Stater, 24014
        • Aktiv, ikke rekrutterende
        • Carilion Roanoke Memorial Hospital

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år og ældre (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Beskrivelse

Include Criteria:

  1. Thoracoabdominal, pararenal or juxtarenal aortic aneurysm with a diameter ≥ 55 mm for males and ≥ 50 mm for females
  2. Thoracoabdominal, pararenal or juxtarenal aortic aneurysm with a growth rate of ≥ 5 mm in 6 months
  3. Thoracoabdominal, pararenal or juxtarenal aortic aneurysm with aortic diameter > 2x the normal aortic diameter or saccular aneurysm that warrants treatment in the opinion of the investigator

Exclusion Criteria:

  1. Age < 18 years
  2. Life expectancy < 2 years
  3. Pregnant, breast-feeding, or planning to become pregnant within 60 months
  4. Inability or refusal to give informed consent by the patient or legally authorized representative
  5. Unwilling or unable to comply with the follow-up schedule, required clinical assessments, and imaging
  6. Simultaneous participation in another investigation study, unless the patient is at least 30 days beyond the primary endpoint of any previous study

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Behandling
  • Tildeling: N/A
  • Interventionel model: Enkelt gruppeopgave
  • Maskning: Ingen (Åben etiket)

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: Aorta abdominal aneurisme

Endovascular aneurysm repair

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Composite measure of device technical success and procedural safety
Tidsramme: 30 days post procedure

Percent of patients with device technical success and freedom from procedural safety events in the following criteria:

  1. Device technical success which includes delivery, deployment, and withdrawal of the device without the need for unanticipated corrective intervention), and
  2. Freedom from the following procedural safety events: rupture, aneurysm-related mortality, permanent paraplegia, new onset renal failure requiring dialysis, bowel ischemia requiring surgery, and disabling stroke
30 days post procedure
Composite measure of freedom from aneurysm-related mortality and clinically significant reintervention
Tidsramme: 12 months post procedure

Percent of patients meeting the following criteria:

  1. Freedom from aneurysm-related mortality (death from aneurysm rupture, death from any cause occurring within 30 days of procedure or secondary intervention or device or procedure related death) and
  2. Freedom from clinically significant reintervention (including open surgery to restore blood flow or restore bodily function, any device related intervention requiring hospitalization, placement of an additional endovascular graft component(s), placement of a stent(s) as indicated for loss of or for having inadequate fixation, seal or patency)
12 months post procedure

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Sponsor

Efterforskere

  • Ledende efterforsker: Gustavo Oderich, MD, Baylor College of Medicine

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

8. december 2023

Primær færdiggørelse (Anslået)

1. november 2026

Studieafslutning (Anslået)

1. november 2031

Datoer for studieregistrering

Først indsendt

19. april 2021

Først indsendt, der opfyldte QC-kriterier

4. maj 2021

Først opslået (Faktiske)

6. maj 2021

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

6. oktober 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

1. oktober 2026

Sidst verificeret

1. oktober 2026

Mere information

Begreber relateret til denne undersøgelse

Andre undersøgelses-id-numre

  • 17-07

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

UBESLUTET

IPD-planbeskrivelse

Cook Research Incorporated (CRI) is fully committed to supporting the principles of responsible data sharing, including providing qualified scientific researchers access to deidentified, patient-level data from CRI clinical studies to conduct legitimate scientific research. Data underlying the results reported in this clinical study will be made available for request after publication of the results from this study and ending 5 years after initial publication. Interested researchers may review the "Cook Research Incorporated Policy on Access to Clinical Study Data" at https://www.cookresearchinc.com/extranet/data-access.html and submit a complete research proposal to request data access. Additional study documents (such as the study protocol) will be shared as needed if the data access request is granted. A data sharing agreement will be executed for access to deidentified patient-level data.

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ja

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .